Hématologie Lymphome non Hodgkinien
CA-4948-101
An Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients with Relapsed or Refractory Primary Central Nervous System Lymphom.
Saint-Cloud
CAROLE SOUSSAIN